Jupiter Neurosciences, Inc. Common Stock
JUNS
$3.19-5.06%
End of day · as of Oct 14, 2026, 8:00 PM ET
Mkt cap
$9.97M
EV/Sales
283.6
P/E ratio
N/A
FY2025 Revenue
$21,796
EPS (H1 2026)
$-8.00
Gross Margin (FY2025)
80.59%
Profit Margin (FY2025)
-39662.77%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Jupiter Neurosciences, Inc. Common Stock (JUNS) is a biotechnology company listed on NASDAQ.
Latest reported JUNS revenue for 2025-12-31 was $21.8K. Net income was -$8.6M. JUNS currently screens at market cap $10.0M.
Use this JUNS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full JUNS income, balance, and cash tables.
Jupiter Neurosciences, Inc. Common Stock (JUNS) is a biotechnology company in the Healthcare sector.
Latest cached Jupiter Neurosciences, Inc. Common Stock (JUNS) revenue for Dec 31, 2025 was $21.8K. Net income was -$8.6M. Statements: https://lician.com/financials/juns
Jupiter Neurosciences, Inc. Common Stock (JUNS) market capitalization is $10.0M on the latest cached snapshot.
Jupiter Neurosciences, Inc. Common Stock (JUNS) cached previous close $3.36; day range $3.17 – $3.30; volume 19,424. Session quote: https://lician.com/quote/juns
Jupiter Neurosciences, Inc. Common Stock (JUNS) latest cached earnings event is "JUNS earnings" on Aug 17, 2026. Earnings calendar: https://lician.com/earnings
The latest cached JUNS filing is 8-K · Sep 3, 2026. Filings: https://lician.com/sec/juns